Glenmark Pharmaceuticals Ltd.
- ECONOMY
Glenmark Pharma Q1 Review – Steady Traction Exhibited In Domestic Formulation, Rest Of World: Motilal Oswal
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
U.S. FDA Flags Quality Lapse At Glenmark Pharma’s Aurangabad Facility
The U.S. drug regulator has flagged a quality control lapse at Glenmark Pharmaceutical Ltd.’s Aurangabad facility. The U.S. Food and…
Read More » - ECONOMY
Sun Pharma, Glenmark Recall Products In U.S. Due To Manufacturing Issues
Leading drugmakers Sun Pharmaceutical Industries Ltd. and Glenmark Pharmaceuticals Ltd. are recalling products in the U.S., the world’s largest market…
Read More » - ECONOMY
Pharma Q1 Preview – Price Erosions In The U.S., Other Markets To Drive Muted Growth In Sales: KRChoksey
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma, Healthcare Q1 Preview – Expect Tepid Performance With High Base, Elevated Costs: ICICI Securities
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More » - ECONOMY
Pharma Q1 Earnings Preview – Recovery In U.S. But High Domestic Base To Weigh: ICICI Direct
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset…
Read More »